Catherine Owen

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Catherine Owen

Catherine Owen was last confirmed as Board Member at Agios Pharmaceuticals, Inc. (AGIO) in a filing dated April 25, 2025. Agios Pharmaceuticals, Inc. reported in an 8-K filed May 25, 2023 that Catherine Owen was appointed director, effective June 13, 2023.

“On May 23, 2023, the Board, upon the recommendation of the Corporate Governance Committee, elected Catherine Owen as a director, effective as of June 13, 2023.”

Agios Pharmaceuticals, Inc. Form 8-K, filed May 25, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Catherine Owen's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Agios Pharmaceuticals, Inc. (AGIO)
Board Member

Proxy statement

Start not stated–2025-04-25

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Agios Pharmaceuticals, Inc.

AGIO

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: director Agios Pharmaceuticals, Inc. (AGIO)
2023-06-13